Debulking surgery for incompletely operated advanced epithelial ovarian carcinoma

Journal of Surgical Oncology

Volumn 100, Issue 3, 2009, Pages 258-260

  Gultekin, Murat ^a,b   Dursun, Polat ^a   Doǧan, Nasuh U ^a   Kolusari, Ali ^a   Yuce, Kunter ^a   Ayhan, Ali ^a  

^a HACETTEPE UNIVERSITY   (Turkey)

^b Cankiri State Hospital   (Turkey)

Author keywords

Epithelial ovarian cancer; Incomplete surgery; Prognosis; Re operation; Re staging

Indexed keywords

CARBOPLATIN; TAXANE DERIVATIVE;

ADULT; ADVANCED CANCER; AGED; ARTICLE; CANCER SURVIVAL; CONTROLLED STUDY; CYTOREDUCTIVE SURGERY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MULTIPLE CYCLE TREATMENT; OVARY CARCINOMA; PRIORITY JOURNAL; PROGNOSIS; REOPERATION; CARCINOMA; GYNECOLOGIC SURGERY; MIDDLE AGED; MINIMAL RESIDUAL DISEASE; MORTALITY; OVARY TUMOR; PATHOLOGY; RETROSPECTIVE STUDY;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA; FEMALE; GYNECOLOGIC SURGICAL PROCEDURES; HUMANS; MIDDLE AGED; NEOPLASM, RESIDUAL; OVARIAN NEOPLASMS; REOPERATION; RETROSPECTIVE STUDIES;

EID: 70249095611     PISSN: 00224790     EISSN: 10969098     Source Type: Journal    
DOI: 10.1002/jso.21274     Document Type: Article

References (12)

1. Harlan LC, Clegg LX, Trimble EL: Trends in surgery and chemotherapy for women diagnosed with ovarian cancer in the United States. J Clin Oncol 2003;21:3488-3494.
2. Randall TC, Rubin SC: Surgical management of ovarian cancer. Semin Surg Oncol 1999;17:173-180.
3. Ayhan A, Gultekin M, Celik NY, et al.: Occult metastasis in early ovarian cancers: Risk factors and associated prognosis. Am J Obstet Gynecol 2007;196:81. (Pubitemid 46107382)
4. Chan JK, Munro EG, Cheung MK, et al.: Association of lymphadenectomy and survival in stage I ovarian cancer patients. Obstet Gynecol 2007;109:12-19. (Pubitemid 46043192)
5. Leblanc E, Querleu D, Narducci F, et al.: Surgical staging of early invasive epithelial ovarian tumors. Semin Surg Oncol 2000;19:36-41. (Pubitemid 30439313)
6. Le T, Adolph A, Krepart GV, et al.: The benefits of comprehensive surgical staging in the management of early-stage epithelial ovarian carcinoma. Gynecol Oncol 2002;85:351-355.
7. Pomel C, Barton DP, McNeish I, et al.: A statement for extensive primary cytoreductive surgery in advanced ovarian cancer. BJOG 2008;115:808-810. (Pubitemid 351692990)
8. Morrison J, Swanton A, Collins S, et al.: Chemotherapy versus surgery for initial treatment in advanced ovarian epithelial cancer. Cochrane Database Syst Rev 2007; Oct 17: CD005343. (Pubitemid 351805181)
9. Wimberger P, Lehmann N, Kimmig R, et al.: Prognostic factors for complete debulking in advanced ovarian cancer and its impact on survival. An exploratory analysis of a prospectively randomized phase III study of the Arbeitsgemeinschaft Gynaekologische Onkologie Ovarian Cancer Study Group (AGO-OVAR). Gynecol Oncol 2007;106:69-74.
10. Vergote I, van Gorp T, Amant F, et al.: Timing of debulking surgery in advanced ovarian cancer. Int J Gynecol Cancer 2008;18:11-19. (Pubitemid 38898819)
11. Gallo A, Frigerio L: Neoadjuvant chemotherapy and surgical considerations in ovarian cancer. Curr Opin Obstet Gynecol 2003;15:25-31. (Pubitemid 36143489)
12. van der Burg ME, van Lent M, Buyse M, et al.: The effect of debulking surgery after induction chemotherapy on the prognosis in advanced epithelial ovarian cancer. Gynecological Cancer Cooperative Group of the European Organization for Research and Treatment of Cancer. N Engl J Med 1995;332:629-634.